These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25189886)

  • 21. Livin gene plays a role in drug resistance of colon cancer cells.
    Wang X; Xu J; Ju S; Ni H; Zhu J; Wang H
    Clin Biochem; 2010 May; 43(7-8):655-60. PubMed ID: 20171199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the receptor tyrosine kinase recepteur d'origine nantais and its association with tumor progression in hypopharyngeal cancer.
    Yoon TM; Kim SA; Park YL; Lee KH; Sung MW; Lee JK; Lim SC; Chung IJ; Joo YE
    Head Neck; 2013 Aug; 35(8):1106-13. PubMed ID: 22887469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoform-specific silencing of the Livin gene by RNA interference defines Livin beta as key mediator of apoptosis inhibition in HeLa cells.
    Crnković-Mertens I; Semzow J; Hoppe-Seyler F; Butz K
    J Mol Med (Berl); 2006 Mar; 84(3):232-40. PubMed ID: 16437214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.
    Altieri B; Sbiera S; Della Casa S; Weigand I; Wild V; Steinhauer S; Fadda G; Kocot A; Bekteshi M; Mambretti EM; Rosenwald A; Pontecorvi A; Fassnacht M; Ronchi CL
    Oncotarget; 2017 Feb; 8(6):9323-9338. PubMed ID: 28030838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitor of apoptosis protein Livin promotes tumor progression and chemoradioresistance in human anaplastic thyroid cancer.
    Kim HK; Kim SA; Jung EK; Lee KH; Lee JK; Kang HC; Joo YE; Lim SC; Yoon TM
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The anti-apoptotic livin gene is an important determinant for the apoptotic resistance of non-small cell lung cancer cells.
    Crnković-Mertens I; Muley T; Meister M; Hartenstein B; Semzow J; Butz K; Hoppe-Seyler F
    Lung Cancer; 2006 Nov; 54(2):135-42. PubMed ID: 16965834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of siRNA on expression of livin and dose- and time-response in human malignant melanoma LiBr cells].
    Wang H; Tan SS; Wang XY; Liu DH; Yu CS; Bai ZL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Aug; 23(8):741-4. PubMed ID: 17618569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of Livin in colorectal cancer and its relationship to tumor cell behavior and prognosis.
    Myung DS; Park YL; Chung CY; Park HC; Kim JS; Cho SB; Lee WS; Lee KH; Lee JH; Joo YE
    PLoS One; 2013; 8(9):e73262. PubMed ID: 24023847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells.
    Wang R; Lin F; Wang X; Gao P; Dong K; Zou AM; Cheng SY; Wei SH; Zhang HZ
    Cancer Gene Ther; 2008 Jun; 15(6):402-12. PubMed ID: 18340356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of RNA interference-mediated knockdown of livin and survivin using monomethoxypolyethylene glycol-chitosan nanoparticles in MG-63 osteosarcoma cells.
    Guan HP; Sun JZ; Feng XL; Chen JS; Chen FJ; Cheng XF; Liu XW; Ni B
    Mol Med Rep; 2016 Feb; 13(2):1821-6. PubMed ID: 26708654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated.
    Yin L; Liu S; Li C; Ding S; Bi D; Niu Z; Han L; Li W; Gao D; Liu Z; Lu J
    Tumour Biol; 2016 Sep; 37(9):12731-12742. PubMed ID: 27448305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of apoptosis inhibitor gene Livin in bladder transitional cell carcinoma and clinical implication thereof].
    Song T; Hong BF; Gao JP; Cai W; Wang CY
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):806-7. PubMed ID: 17565859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of shRNA-silenced livin and survivin on lung cancer cell proliferation and apoptosis.
    Zhao X; Yuan Y; Zhang Z; Feng X; Zhang J; Yuan X; Li J
    J BUON; 2014; 19(3):757-62. PubMed ID: 25261663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of livin expression suppresses cell proliferation and enhances chemosensitivity to cisplatin in human lung adenocarcinoma cells.
    Zhuang L; Shen LD; Li K; Yang RX; Zhang QY; Chen Y; Gao CL; Dong C; Bi Q; Tao JN; Wang XN; Tian Q
    Mol Med Rep; 2015 Jul; 12(1):547-52. PubMed ID: 25695324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of monomethoxypolyethylene glycol-chitosan nanoparticle-mediated dual silencing of livin and survivin genes in prostate cancer PC-3M cells.
    Yang AQ; Wang PJ; Huang T; Zhou WL; Landman J
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the apoptosis inhibitor livin in colorectal adenoma-carcinoma sequence: correlations with pathology and outcome.
    Wang Y; Li Y; Zhou B; Zhang WY; Guan JT; Wang R; Yang L; Xia QJ; Zhou ZG; Sun XF
    Tumour Biol; 2014 Dec; 35(12):11791-8. PubMed ID: 25339450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme.
    Hsieh CH; Lin YJ; Wu CP; Lee HT; Shyu WC; Wang CC
    Clin Cancer Res; 2015 Jan; 21(2):460-70. PubMed ID: 25370472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. siRNA targeting Livin decreases tumor in a xenograft model for colon cancer.
    Oh BY; Lee RA; Kim KH
    World J Gastroenterol; 2011 May; 17(20):2563-71. PubMed ID: 21633662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer.
    Hariu H; Hirohashi Y; Torigoe T; Asanuma H; Hariu M; Tamura Y; Aketa K; Nabeta C; Nakanishi K; Kamiguchi K; Mano Y; Kitamura H; Kobayashi J; Tsukahara T; Shijubo N; Sato N
    Clin Cancer Res; 2005 Feb; 11(3):1000-9. PubMed ID: 15709165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
    Wong JC; Bathina M; Fiscus RR
    J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.